You are here: Industry Insights > placebo

News List

FDA expands approval for AbbVie’s Skyrizi for active psoriatic arthritis Pharmaceutical-Technology
January 26, 2022
The FDA approval is based on data from two Skyrizi Phase III trials, KEEPsAKE-1 and KEEPsAKE-2.
Placebo effect accounts for more than two-thirds of COVID-19 vaccine adverse events WorldPharmaNews
January 20, 2022
The placebo effect is the well-known phenomenon of a person's physical or mental health improving after taking a treatment with no pharmacological therapeutic benefit - a sugar pill, or a syringe full of saline, for example.
Tools4Patient Announces Name Change to Cognivia & Expands Board of Directors prnasia
January 06, 2022
Cognivia today announced a new name for the company formerly known as Tools4Patient, which provides clinical trials solutions based on AI / ML that account for individual patient personality traits...
Novavax’s COVID-19 vaccine highly effective in preventing disease EuropeanPharmaceuticalReview
December 20, 2021
Recently published data suggests Novavax’s investigational COVID-19 vaccine, NVX-CoV2373, is 90 percent effective at preventing COVID-19 illness and 100 percent effective at preventing moderate-to-severe symptoms.
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection Drugs
November 26, 2021
Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address acute medical conditions and public health threats...
Crohn’s patients achieve 65 percent clinical remission with Tremfya® EuropeanPharmaceuticalReview
November 18, 2021
Janssen has announced topline results from the Phase II GALAXI 1 clinical trial which showed rates of clinical remission – Crohn’s Disease Activity Index [CDAI]<150 – previously reported at week 12 increased at week...
Wegovy™ Demonstrated Significant and Sustained Weight Loss in Two-Year Study in Adults With Obesity prnasia
November 08, 2021
Results from the STEP 5 phase 3b trial, presented today at the ObesityWeek® 2021 interactive congress, showed that adults treated with Wegovy™ (semaglutide 2.4 mg injection) achieved significant and sustained weight loss over the two-year study period.
MDMA-assisted therapy successful in PTSD patients europeanpharmaceuticalreview
May 12, 2021
Three sessions of MDMA-assisted talk therapy resulted in significant symptom reductions for 88 percent of patients with severe, chronic post-traumatic stress disorder (PTSD).
Novavax allows giving COVID-19 vaccine to trial participants on placebo expresspharma
April 07, 2021
Allowing volunteers to crossover to the active vaccine offers them an incentive to continue in the trials even when other authorised vaccines are available.
Deception is not necessary for the placebo effect, finds new study europeanpharmaceuticalreview
April 02, 2021
The study found that patients with irritable bowel syndrome taking open-label placebo reported similar improvements to those taking double-blind placebo.

Previous page 1 2 3 Next page